ACUTE LYMPHOBLASTIC LEUKEMIA WITH FAILED REMISSION
Clinical trials for ACUTE LYMPHOBLASTIC LEUKEMIA WITH FAILED REMISSION explained in plain language.
Never miss a new study
Get alerted when new ACUTE LYMPHOBLASTIC LEUKEMIA WITH FAILED REMISSION trials appear
Sign up with your email to follow new studies for ACUTE LYMPHOBLASTIC LEUKEMIA WITH FAILED REMISSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Hospital-Made cancer fighters: new CAR-T trial for leukemia
Disease control Recruiting nowThis study is testing whether a personalized cell therapy called MB-CART19.1 can be manufactured right at the hospital for children and adults with B-cell acute lymphoblastic leukemia that has come back or not responded to standard treatments. The therapy uses the patient's own i…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA WITH FAILED REMISSION
Phase: NA • Sponsor: King Hussein Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New hope for tough blood cancers: venetoclax combo enters human trials
Disease control Recruiting nowThis early-phase trial is testing whether adding the drug venetoclax to standard chemotherapy is safe and tolerable for children, adolescents, and young adults with high-risk blood cancers like MDS, AML, and ALL. About 30 participants will receive different combinations of chemot…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA WITH FAILED REMISSION
Phase: PHASE1 • Sponsor: Andrew E. Place, MD • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC